Fervers Bèatrice, Remy-Stockinger Magali, Mazeau-Woynar Valèrie, Otter Renèe, Liberati Alessandro, Littlejohns Peter, Qureshi Safia, Vlayen Joan, Characiejus Dainius, Corbacho Belèn, Garner Sarah, Hamza-Mohamed Farida, Hermosilla Teresa, Kersten Sonja, Kulig Michael, Leshem Benny, Levine Nava, Ballini Luciana, Middelton Clifford, Mlika-Cabane Najoua, Paquet Louise, Podmaniczki Erzsèbet, Ramaekers Dirk, Robinson Eliezer, Sanchez Emilia, Philip Thierry
Fédération Nationale des Centres de Lutte Contre le Cancer SOR/Centre Léon Bérard, EA 4129 Santé-Individu-Société, Lyon, France.
Tumori. 2008 Mar-Apr;94(2):154-9. doi: 10.1177/030089160809400204.
All European countries are facing common challenges for delivering appropriate, evidence-based care to patients with cancer. Despite tangible improvements in diagnosis and treatment, marked differences in cancer survival exist throughout Europe. The reliable translation of new research evidence into consistent patient-oriented strategies is a key endeavour to overcome inequalities in healthcare. Clinical-practice guidelines are important tools for improving quality of care by informing professionals and patients about the most appropriate clinical practice. Guideline programmes in different countries use similar strategies to achieve similar goals. This results in unnecessary duplication of effort and inefficient use of resources. While different initiatives at the international level have attempted to improve the quality of guidelines, less investment has been made to overcome existing fragmentation and duplication of effort in cancer guideline development and research. To provide added value to existing initiatives and foster equitable access to evidence-based cancer care in Europe, CoCanCPG will establish cooperation between cancer guideline programmes. CoCanCPG is an ERA-Net coordinated by the French National Cancer Institute with 17 partners from 11 countries. The CoCanCPG partners will achieve their goal through an ambitious, stepwise approach with a long-term perspective, involving: 1. implementing a common framework for sharing knowledge and skills; 2. developing shared activities for guideline development; 3. assembling a critical mass for pertinent research into guideline methods; 4. implementing an appropriate framework for cooperation. Successful development of joint activities involves learning how to adopt common quality standards and how to share responsibilities, while taking into account the cultural and organisational diversity of the participating organisations. Languages barriers and different organisational settings add a level of complexity to setting up transnational collaboration. Through its activities, CoCanCPG will make an important contribution towards better access to evidence-based cancer practices and thus contribute to reducing inequalities and improving care for patients with cancer across Europe.
所有欧洲国家在为癌症患者提供恰当的、基于证据的治疗方面都面临着共同挑战。尽管在诊断和治疗方面有了切实改善，但整个欧洲的癌症生存率仍存在显著差异。将新的研究证据可靠地转化为一致的以患者为导向的策略，是克服医疗保健不平等现象的一项关键努力。临床实践指南是通过向专业人员和患者告知最合适的临床实践来提高医疗质量的重要工具。不同国家的指南项目采用类似策略以实现类似目标。这导致了不必要的工作重复和资源利用效率低下。虽然国际层面的不同举措试图提高指南质量，但在克服癌症指南制定和研究中现有的碎片化和工作重复方面投入较少。为了为现有举措增添价值并促进欧洲公平获得基于证据的癌症治疗，CoCanCPG将在癌症指南项目之间建立合作。CoCanCPG是一个由法国国家癌症研究所协调的欧洲研究区域网络，有来自11个国家的17个合作伙伴。CoCanCPG的合作伙伴将通过一种雄心勃勃、具有长期视角的逐步方法来实现其目标，包括：1. 实施一个共享知识和技能的共同框架；2. 开展指南制定的共享活动；3. 聚集大量人员对指南方法进行相关研究；4. 实施一个合适的合作框架。成功开展联合活动涉及学习如何采用共同的质量标准以及如何分担责任，同时考虑到参与组织的文化和组织多样性。语言障碍和不同的组织环境给建立跨国合作增加了一定的复杂性。通过其活动，CoCanCPG将为更好地获得基于证据的癌症治疗方法做出重要贡献，从而有助于减少不平等现象并改善全欧洲癌症患者的护理。
